KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $16.2 billion.

  • Quest Diagnostics' Liabilities and Shareholders Equity rose 0.63% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $64.1 billion, marking a year-over-year increase of 10.64%. This contributed to the annual value of $16.2 billion for FY2024, which is 15.20% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Liabilities and Shareholders Equity is $16.2 billion, which was up 1.43% from $16.0 billion recorded in Q2 2025.
  • Quest Diagnostics' 5-year Liabilities and Shareholders Equity high stood at $16.2 billion for Q3 2025, and its period low was $12.8 billion during Q1 2023.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $14.0 billion (2023), whereas its average is $14.7 billion.
  • Per our database at Business Quant, Quest Diagnostics' Liabilities and Shareholders Equity declined by 5.69% in 2022 and then increased by 19.38% in 2024.
  • Over the past 5 years, Quest Diagnostics' Liabilities and Shareholders Equity (Quarterly) stood at $13.6 billion in 2021, then fell by 5.69% to $12.8 billion in 2022, then climbed by 9.23% to $14.0 billion in 2023, then climbed by 15.20% to $16.2 billion in 2024, then increased by 0.63% to $16.2 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $16.2 billion for Q3 2025, versus $16.0 billion for Q2 2025 and $15.8 billion for Q1 2025.